Lanean...
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
BACKGROUND: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. METHODS: We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospit...
Gorde:
| Argitaratua izan da: | N Engl J Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Massachusetts Medical Society
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220972/ https://ncbi.nlm.nih.gov/pubmed/34133855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2102605 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|